19 June 2013
Keywords: merck, kgaa, halts, diabetes, projects, germany-based, decided
Article | 09 June 2003
Germany-based Merck KGaA has decided to discontinue two early-stage diabetes projects. The company noted that this is a strategic move ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 June 2003
9 June 2003
18 June 2013
© 2013 thepharmaletter.com